FDA Warns About Treating COVID-19 With Unproven Drugs
Chloroquine, hydroxychloroquine may trigger potentially fatal heart rhythm problems in COVID-19 patients
Premature Posting of Remdesivir Findings Were ‘Inconclusive’
Due to low enrollment, study was 'underpowered to enable statistically meaningful conclusions'
COVID-19 Pandemic Delays FDA Review of Vaping Products
Federal court has granted FDA request to delay May 12 deadline to Sept. 9
Americans Report Concerns Over Their Mental Health During Pandemic
Counseling experts encourage activities to maintain connections and improve mental health
COVID-19-Linked Changes Reported in Rheumatic Disease Patient Care
Forty-two percent of patients report change in care in previous two weeks
More Than One in Five Children in Home Confinement Report Depression
22.6, 18.9 percent of students in COVID-19-linked home confinement report depressive, anxiety symptoms
Low Doses of Bevacizumab Tested for Retinopathy of Prematurity
Phase 1 study suggests that intravitreous injection of 0.004 mg may be lowest effective dose
Prevalence of Hypertension in U.S. 45.4 Percent in 2017 to 2018
Prevalence higher among men than women, in non-Hispanic blacks, and increased with age
Review: MMR, MMRV, MMR+V Vaccines Are Effective, Safe
Review confirms vaccines effective for preventing disease, not associated with increased risk for autism
Infection Rate Up Prior to Detection of Malignant Cancer
Increased odds of influenza, gastroenteritis, hepatitis, pneumonia seen one year before detection
